Cargando…
Anti-Pentraxin Antibodies in Autoimmune Diseases: Bystanders or Pathophysiological Actors?
Pentraxins are soluble innate immunity receptors involved in sensing danger molecules. They are classified as short (CRP, SAP) and long pentraxin subfamilies, including the prototypic long pentraxin PTX3. Pentraxins act mainly as bridging molecules favoring the clearance of microbes and dead cells....
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7921723/ https://www.ncbi.nlm.nih.gov/pubmed/33664737 http://dx.doi.org/10.3389/fimmu.2020.626343 |
_version_ | 1783658526186405888 |
---|---|
author | Brilland, Benoit Vinatier, Emeline Subra, Jean-François Jeannin, Pascale Augusto, Jean-François Delneste, Yves |
author_facet | Brilland, Benoit Vinatier, Emeline Subra, Jean-François Jeannin, Pascale Augusto, Jean-François Delneste, Yves |
author_sort | Brilland, Benoit |
collection | PubMed |
description | Pentraxins are soluble innate immunity receptors involved in sensing danger molecules. They are classified as short (CRP, SAP) and long pentraxin subfamilies, including the prototypic long pentraxin PTX3. Pentraxins act mainly as bridging molecules favoring the clearance of microbes and dead cells. They are also involved in many other biological processes, such as regulation of complement activation, inflammation and tissue homeostasis. Autoantibodies directed against pentraxins have been reported in various autoimmune diseases, especially in systemic lupus erythematosus and ANCA-associated vasculitis. In this review, we review the main biological characteristics and functions of pentraxins and summarize data concerning autoantibodies directed against pentraxins in the context of autoimmune diseases and discuss their potential pathological role. |
format | Online Article Text |
id | pubmed-7921723 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-79217232021-03-03 Anti-Pentraxin Antibodies in Autoimmune Diseases: Bystanders or Pathophysiological Actors? Brilland, Benoit Vinatier, Emeline Subra, Jean-François Jeannin, Pascale Augusto, Jean-François Delneste, Yves Front Immunol Immunology Pentraxins are soluble innate immunity receptors involved in sensing danger molecules. They are classified as short (CRP, SAP) and long pentraxin subfamilies, including the prototypic long pentraxin PTX3. Pentraxins act mainly as bridging molecules favoring the clearance of microbes and dead cells. They are also involved in many other biological processes, such as regulation of complement activation, inflammation and tissue homeostasis. Autoantibodies directed against pentraxins have been reported in various autoimmune diseases, especially in systemic lupus erythematosus and ANCA-associated vasculitis. In this review, we review the main biological characteristics and functions of pentraxins and summarize data concerning autoantibodies directed against pentraxins in the context of autoimmune diseases and discuss their potential pathological role. Frontiers Media S.A. 2021-02-16 /pmc/articles/PMC7921723/ /pubmed/33664737 http://dx.doi.org/10.3389/fimmu.2020.626343 Text en Copyright © 2021 Brilland, Vinatier, Subra, Jeannin, Augusto and Delneste http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Immunology Brilland, Benoit Vinatier, Emeline Subra, Jean-François Jeannin, Pascale Augusto, Jean-François Delneste, Yves Anti-Pentraxin Antibodies in Autoimmune Diseases: Bystanders or Pathophysiological Actors? |
title | Anti-Pentraxin Antibodies in Autoimmune Diseases: Bystanders or Pathophysiological Actors? |
title_full | Anti-Pentraxin Antibodies in Autoimmune Diseases: Bystanders or Pathophysiological Actors? |
title_fullStr | Anti-Pentraxin Antibodies in Autoimmune Diseases: Bystanders or Pathophysiological Actors? |
title_full_unstemmed | Anti-Pentraxin Antibodies in Autoimmune Diseases: Bystanders or Pathophysiological Actors? |
title_short | Anti-Pentraxin Antibodies in Autoimmune Diseases: Bystanders or Pathophysiological Actors? |
title_sort | anti-pentraxin antibodies in autoimmune diseases: bystanders or pathophysiological actors? |
topic | Immunology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7921723/ https://www.ncbi.nlm.nih.gov/pubmed/33664737 http://dx.doi.org/10.3389/fimmu.2020.626343 |
work_keys_str_mv | AT brillandbenoit antipentraxinantibodiesinautoimmunediseasesbystandersorpathophysiologicalactors AT vinatieremeline antipentraxinantibodiesinautoimmunediseasesbystandersorpathophysiologicalactors AT subrajeanfrancois antipentraxinantibodiesinautoimmunediseasesbystandersorpathophysiologicalactors AT jeanninpascale antipentraxinantibodiesinautoimmunediseasesbystandersorpathophysiologicalactors AT augustojeanfrancois antipentraxinantibodiesinautoimmunediseasesbystandersorpathophysiologicalactors AT delnesteyves antipentraxinantibodiesinautoimmunediseasesbystandersorpathophysiologicalactors |